Drug Trial Radar · NCT00074581
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
Last checked: Nov 19, 2026Latest source record: Nov 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,526
Actual
Start
Feb 2005
Primary completion
May 2015
Study completion May 2015
Sponsor
- Sponsor type
- NIH
- Collaborators
- HIV Prevention Trials Network
- First posted
- Dec 17, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will determine whether anti-HIV drugs can prevent the sexual transmission of HIV among couples in which one partner is HIV infected and the other is not.
Conditions
- HIV Infections
Interventions
AtazanavirDrug
300 mg taken orally once daily
DidanosineDrug
400 mg taken orally once daily
EfavirenzDrug
600 mg taken orally once daily
Emtricitabine/Tenofovir disoproxil fumarateDrug
200 mg emtricitabine/ 300 mg tenofovir disoproxil fumarate tablet taken orally once daily
LamivudineDrug
300 mg taken orally once daily
Lopinavir/RitonavirDrug
200 mg lopinavir/ 50 mg ritonavir tablet taken orally once daily
NevirapineDrug
200 mg taken orally once daily for 14 days followed by 200 mg taken orally twice daily
StavudineDrug
Dosage depends on weight
Tenofovir disoproxil fumarateDrug
300 mg taken orally once daily
Zidovudine/LamivudineDrug
150 mg lamivudine/ 300 mg zidovudine tablet taken orally twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Linked Partner HIV Infection Rates in Early-ART and Delayed-ART ArmsTime frame: Throughout study
- All Partner HIV Infection Rates in Early-ART and Delayed-ART ArmsTime frame: Throughout study
Locations
17 sites in 9 countries. Site status is shown where the registry gives one.
Fenway Community Health Ctr. CRS
Boston, Massachusetts
Gaborone CRS
Gaborone, Botswana
HSE-Hospital dos Servidores do Estado CRS
Rio de Janeiro, Brazil
Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS
Rio de Janeiro, Brazil
Hospital Geral de Nova Iguaçu CRS (HGNI CRS)
Nova Iguaçu, Rio de Janeiro, Brazil
Hospital Nossa Senhora da Conceicao CRS
Port Alegre, Rio Grande do Sul, Brazil
NARI Clinic at Gadikhana Dr. Kotnis Municipal Dispensary CRS
Pune, Maharashtra, India
NARI Clinic at NIV CRS
Pune, Maharashtra, India
NARI Pune CRS
Pune, Maharashtra, India
Chennai Antiviral Research and Treatment (CART) CRS
Chennai, Tamil Nadu, India
Kisumu Crs
Kisumu, Nyanza, Kenya
Blantyre CRS
Blantyre, Malawi
Malawi CRS
Lilongwe, Malawi
Soweto HPTN CRS
Johannesburg, Gauteng, South Africa
Wits Helen Joseph Hospital CRS (Wits HJH CRS)
Johannesburg, Gauteng, South Africa
CMU HIV Prevention CRS
Chiang Mai, Thailand
Parirenyatwa CRS
Harare, Zimbabwe
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.